Risk per UNIT Allergic 3100 Febrile Leuko reduced Units 1100 TACO 1100 TRALI 15000 Sepsis 15000 Acute hemolytic 175000 HBV 1160000 HIV amp HCV 12 million ID: 929661
Download Presentation The PPT/PDF document "Transfusion Complication" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Transfusion ComplicationRisk per UNIT Allergic3:100Febrile (Leuko-reduced Units)1:100TACO1:100TRALI1:5,000Sepsis1:5,000Acute hemolytic1:75,000HBV1:160,000HIV & HCV1:2 million
Blood product consent form checklist:Reasons for transfusionRisks of transfusion vs benefitAlternative treatments (if any)** Must give Pts opportunity to ask questions!**
-Type and Screen: Determines ABO type & Rh status and screens for non-ABO RBC antibodies. - AT UNMH, crossmatch is done when orders to transfuse are submitted in Powerchart. Blood is held by blood bank until pick up at time of transfusion.
UNMH Blood Bank 272-0992
Premedication with acetaminophen is only advised for patients already receiving anti-pyretics.Premedication with diphenhydramine is only advised for patients with REPEAT allergic reactions.
Blood Products and Indications
Packed
red blood cells (PRBCs)
For hemodynamically stable patients
without active bleeding
:
-
Hgb
<
7 g/
dL
- Generally indicated
- Hgb 7 - 8 g/
dL
- Consider in pre-op
Pts
&
Pts
w
stable cardiovascular
disease
-
Hgb
8 - 10 g/
dL
- Consider
in select Pts
only (symptomatic anemia, cardiac ischemia).
For actively bleeding patients,
transfuse as needed to maintain adequate oxygenation
Notes:
1 U PRBC ≈ 300mL, 1 U PRBC =>↑
Hb
̴ 1 g/
dL
, Large trxn→↓
Ca
,↑K, ↓ Coagulation factors
Platelets
(
plts
)
- <10,000/
μ
L Generally indicated or <20,000/
μ
L w/ infection/line placement/minor biopsy
- <50,000/
μ
L With active bleeding or prior to moderate-high risk invasive procedure
- <100,000 Neurosurgery or ocular surgery
*Threshold-based trxn not appropriate for Pts bleeding 2
°
to platelet dysfunction
Notes: 1 U Apheresis
plt
≈ 300mL ≈ “6 pack” of pooled
plts
=>↑
plt
count ̴ 25,000
/μ
L.
Refractory =
Pts
with < 5000
/μ
L
plt
↑ 15-60 min post
txn
x 2 after r/o other causes (e.g. drugs)
Plasma
(FFP)
- C
orrection of bleeding
2
°
to↓ in multiple
coag
factors (
eg
,
warfarin,
vit
K
def
, DIC, liver disease, dilution)
Consider lower risk coagulation factor complex (e.g.
Bebulin
)
- Prophylactic use in non-bleeding
Pts
prior to mod-high risk procedures when INR>2.*
*Available studies do not support the efficacy of FFP as prophylaxis for most invasive procedures in patients with a mild coagulopathy (
ie
, INR <2.0)
Notes:
1U FFP
≈ 250mL, Initial dose: 15 mL/kg ( ̴ 3 to 5 units of FFP for
average
adult).
Transfuse close to time of procedure due to short half-life of coagulation factors
Cryo
-precipitate (
Cryo
)
- Correction of significant bleeding 2° ↓fibrinogen (<160)
- Emergency
use for bleeding in
vWD
Pts
Notes: 1 U of
cryo
≈ 10-20 mL, 10U of
cryo
will ↑ fibrinogen ̴70 mg/
dL
in 70kg
Pt
Irradiated
(IRR)
To
prevent
Txn
-assoc.
GVHD
(
eg
, in
Pts
w/cellular immune-
def
, stem cell recipients, premature neonates,
heme
malignancies, and
Pts
receiving
Fludarabine
or
Cladribine
, HLA matched
plts
or directed units.) *
May cause delay in availability
Leuko-reduced
To ↓ Risk of febrile
rxns
, ↓ risk of trxn transmission of CMV.
Notes: Risk of CMV transmission w/
leukoreduction
≈ risk w/CMV
sero
-negative products
**All blood products at UNM (with the exception of granulocytes) are pre-storage
leukoreduced
**
Washed
To
↓ risk of allergic
rxns
for
Pts
with h/o prior
severe
allergic
rxn
. Rarely indicated.
NOT recommended for platelets (reduces yield ~ ½,
plts
less functional)
Slide2Acute Transfusion Reactions Febrile non-hemolyticSymptoms & Signs*: Fever (>1C°↑ and >38°) and chills Severity: Low morbidityDdx: Acute Hemolytic Rxn, Sepsis & TRALIPrevention & Tx: Prevented by using leukoreduced products.In RCTs acetaminophen not shown to ↓ incidence; premed advised only if Pt is already febrile. Allergic/AnaphylacticSymptoms & Signs*: Urticaria, pruritus Anaphylaxis =>Dyspnea, tightening of throat, ↓BPSeverity: Low morbidity (simple allergic) to life threatening (anaphylaxis)Ddx: TRALI, TACO (consider both in Pt’s with shortness of breath)Prevention & Tx: Reactions dose-dependent => STOP Trxn and wait for symptoms to resolve with treatment. For repeated rxns, consider pre-medication with diphenhydramine, famotidine and/or steroids. Rx anaphylaxis w/ Epi. Consider washed units for Pts with h/o anaphylaxis. Acute HemolyticSymptoms & Signs*: Fever, chills, hypotension, dyspnea, chest pain, flank pain, and anxietySeverity: Life threatening
Ddx: Febrile Non-Hemolytic, Sepsis, TRALIPrevention & Tx:
Proper ID of Pt and blood product. Only transfuse RBC with normal saline. Maintain urine output (IV fluids, mannitol and/or diuretics), CV support.
TACO(Transfusion –Assoc. Circulatory Overload)
Symptoms & Signs*: Dyspnea, hypertension, hypoxia, pulmonary edema, ↑BNP
Severity:
Moderate morbidity to life threateningDdx: TRALI, Acute Hemolytic Transfusion Rxn, Anaphylaxis, Non-Txn ARDSPrevention & Tx: Conservative transfusion, ID at risk Pts (eg, elderly, h/o heart disease, and pediatric Pts) and transfuse slowly over max of 4hrs . Rx with supplemental O2 and diuretics. TRALI(Transfusion-Related Acute Lung Injury)Symptoms & Signs*: SOB, fever, hypoxia, pulmonary edema, ↓ BP, within 6 hrs of transfusion. Severity: Life threateningDdx: TACO, Sepsis, Acute Hemolytic Transfusion Reaction, Anaphylaxis, non-Trxn ARDS Prevention & Tx: Conservative transfusion. Treat like ARDS.SepsisSymptoms & Signs*: Hypotension, fever, and rigorsSeverity: Life threateningDdx: Acute Hemolytic Transfusion Rxn, TRALI, Febrile Non-Hemolytic RxnPrevention & Tx: Bacterial testing of blood units. Rx w/antibiotics and supportive care.
2013 UNMH Transfusion Service (Ramos, Reyes, Crookston & Koenig)
Draw 2 purple tops and send to BB with remainder of unit for trxn rxn work-up. Send urine if s/s of hemolysis. Unless emergent, wait for results and pathology approval to transfuse another unit.
Transfusion
Reaction Suspected
STOP Transfusion
Fill out Trxn Rxn form & call Blood Bank
Trxn can resume AFTER symptoms resolve (Rx with diphenhydramine)
Itching and hives
only
All other symptoms
-
Stabilize patient
- Notify attending
- Perform Clerical Check
*
Not all signs and symptoms may be present